| Overall | TAF/FTC/EVG/cobi | TAF/FTC/RPV | ABC/3TC/DTG |
---|---|---|---|---|
N = 560 | n = 170 (30.4%) | n = 191 (34.1%) | n = 199 (35.5%) | |
Gender, n (%) | ||||
 Female | 126 (22.5) | 41 (24.1) | 38 (19.9) | 47 (23.6) |
 Male | 434 (77.5) | 129 (75.9) | 153 (80.1) | 152 (76.4) |
Age (years), median [IQR] | 49.00 [41.00, 55.00] | 48.00 [38.25, 55.00] | 48.00 [40.50, 54.00] | 50.00 [43.00, 55.00] |
Risk group, n (%) | ||||
 Heterosexual | 233 (41.6) | 75 (44.1) | 76 (39.8) | 82 (41.2) |
 IVDU | 65 (11.6) | 16 (9.4) | 19 (9.9) | 30 (15.1) |
 MSM | 234 (41.8) | 71 (41.8) | 86 (45.0) | 77 (38.7) |
 Other | 28 (5.0) | 8 (4.7) | 10 (5.2) | 10 (5.0) |
Smoke, n (%) | 220 (39.3) | 77 (45.3) | 65 (34.0) | 78 (39.2) |
Weight (kg), median [IQR] | 72.00 [64.00, 80.00] | 71.50 [63.05, 80.75] | 73.00 [66.00, 81.00] | 70.00 [63.00, 78.00] |
BMI, median [IQR] | 24.01 [21.97, 25.98] | 23.70 [21.68, 25.86] | 24.39 [22.49, 26.22] | 23.94 [21.85, 25.97] |
Systolic blood pressure (mmHg), median [IQR] | 120.00 [110.00, 130.00] | 120.00 [110.00, 130.00] | 120.00 [110.00, 130.00] | 120.00 [110.00, 130.00] |
Diastolic blood pressure (mmHg), median [IQR] | 80.00 [70.00, 80.00] | 80.00 [70.00, 80.00] | 80.00 [70.00, 80.00] | 80.00 [70.00, 80.00] |
Previous therapy duration (years), median [IQR] | 10.36 [4.96, 16.88] | 9.94 [3.19, 16.22] | 8.71 [4.56, 15.11] | 11.47 [6.70, 18.02] |
Previous AIDS, n (%) | 111 (19.8) | 39 (22.9) | 32 (16.8) | 40 (20.1) |
Treated with ASA, n (%) | 38 (6.8) | 9 (5.3) | 10 (5.2) | 19 (9.5) |
Treated with anti-hypertensive agent, n (%) | 101 (18.0) | 31 (18.2) | 32 (16.8) | 38 (19.1) |
Treated with oral hypoglycemic agents / insulin, n (%) | 18 (3.2) | 3 (1.8) | 8 (4.2) | 7 (3.5) |
Treated with lipid-lowering agents other than statins a, n (%) | 43 (7.7) | 16 (9.4) | 12 (6.3) | 15 (7.5) |
Treated with statins, n (%) | 88 (15.7) | 27 (15.9) | 33 (17.3) | 28 (14.1) |
HCV, n (%) | 121 (21.6) | 28 (16.5) | 40 (20.9) | 53 (26.6) |
HBV, n (%) | 25 (4.5) | 14 (8.2) | 6 (3.1) | 5 (2.5) |
Switch from PI, n (%) | 137 (24.6) | 42 (24.7) | 13 (6.8) | 82 (41.6) |
Switch from TDF, n (%) | 357 (64.1) | 132 (77.6) | 167 (87.9) | 58 (29.4) |
Switch from RTV / cobi, n (%) | 193 (34.5) | 113 (66.5) | 16 (8.4) | 64 (32.2) |
Switch from INI, n (%) | 143 (25.5) | 97 (57.1) | 5 (2.6) | 41 (20.6) |
CD4+ (cells/mmc), median [IQR] | 710.50 [560.00, 893.00] | 681.00 [535.00, 878.75] | 711.00 [566.50, 862.00] | 744.00 [580.00, 961.00] |
Creatinine (mg/dl), median [IQR] | 0.90 [0.79, 1.03] | 0.90 [0.79, 1.01] | 0.94 [0.80, 1.04] | 0.89 [0.76, 1.04] |
eGFR ml/min, median [IQR] | 98.49 [79.96, 118.06] | 97.31 [80.67, 118.45] | 101.24 [81.70, 115.49] | 96.92 [75.87, 118.96] |
Triglycerides (mg/dl), median [IQR] | 115.00 [87.00, 166.00] | 110.50 [88.50, 169.25] | 110.50 [81.25, 150.25] | 122.00 [91.00, 173.00] |
Total cholesterol (mg/dl), median [IQR] | 193.00 [171.00, 215.00] | 192.50 [173.75, 213.50] | 186.00 [169.00, 209.00] | 200.00 [174.00, 224.00] |
HDL cholesterol (mg/dl), median [IQR] | 43.00 [37.00, 52.00] | 43.00 [35.50, 54.00] | 43.00 [37.00, 49.50] | 44.00 [36.00, 52.00] |
LDL cholesterol (mg/dl), median [IQR] | 120.30 [101.40, 143.05] | 121.80 [102.00, 140.80] | 115.80 [100.75, 139.50] | 121.20 [102.40, 153.90] |
Framingham risk score, median [IQR] | 8.25 [4.19, 16.03] | 9.18 [3.92, 18.02] | 7.23 [3.47, 14.11] | 9.23 [5.13, 15.99] |